Business Context and Reporting Period
Company: H.B. Fuller Company (H.B. Fuller)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: August 30, 2025 (Third Quarter of Fiscal Year 2025)
Business Overview: H.B. Fuller is a global manufacturer of functional coatings, adhesives, sealants, and elastomers. The company operates through three primary segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Building Adhesive Solutions. During the period, the company reorganized its segments, moving the former North American Flooring business results to Corporate Unallocated following its divestiture.
Key Financial Metrics
| Metric | Q3 2025 | Q3 2024 | YTD 9M 2025 | YTD 9M 2024 |
|---|---|---|---|---|
| Net Revenue | $892.0 million | $917.9 million | $2,578.8 million | $2,645.5 million |
| Gross Profit | $285.1 million | $275.7 million | $798.6 million | $797.0 million |
| Gross Margin | 32.0% | 30.0% | 31.0% | 30.1% |
| Operating Income | $110.1 million | $104.3 million | $256.6 million | $271.8 million |
| Net Income (Attributable to H.B. Fuller) | $67.2 million | $55.4 million | $122.2 million | $137.6 million |
| Diluted EPS | $1.22 | $0.98 | $2.21 | $2.43 |
| Free Cash Flow (YTD) | $62.2 million | $104.0 million | ||
| Cash & Equivalents (End of Period) | ||||
| Total Debt | $2,080.5 million | $2,010.6 million (Nov 30, 2024) |
Material Changes vs. Prior Period
- Revenue Decline: Q3 2025 net revenue decreased 2.8% year-over-year. This was driven by a 2.9% decrease from acquisitions/divestitures (primarily the sale of the North American Flooring business) and a 1.9% decrease in sales volume. These were partially offset by a 1.0% increase from pricing and a 1.0% positive currency impact.
- Margin Expansion: Gross profit margin improved by 200 basis points in Q3 2025 compared to Q3 2024, reaching 32.0%. This improvement was attributed to higher product pricing, lower distribution costs, and the impact of M&A activity.
- Profitability: Despite lower revenue, Net Income attributable to H.B. Fuller increased 21.3% in Q3 2025 to $67.2 million, driven by margin expansion and lower interest expense. However, on a Year-to-Date (YTD) basis, Net Income decreased 11.2% to $122.2 million.
- Segment Performance:
- Engineering Adhesives: Revenue increased 4.7% and Operating Income increased 16.7%, driven by organic growth (pricing and volume) and the acquisition of ND Industries Taiwan.
- Hygiene, Health and Consumable Adhesives: Revenue was flat YTD but Operating Income decreased 17.9% due to higher raw material costs and SG&A expenses.
- Building Adhesive Solutions: Revenue increased 2.3% due to M&A (HS Butyl acquisition), though operating income remained relatively flat.
- Restructuring: The company has incurred $69.7 million of costs under its restructuring plans as of August 30, 2025, with total expected costs ranging from $70.0 million to $75.0 million.
Guidance, Outlook, and Risks
- Capital Allocation: The company continues to focus on capital allocation toward high-margin, high-growth market segments. Recent acquisitions (GEM, Medifill, ND Industries Taiwan, HS Butyl) are intended to accelerate growth in medical and engineering adhesives.
- Liquidity: Management believes cash flows from operations will be adequate to meet short-term and long-term needs. The company remains in compliance with all debt covenants, with a Secured Total Indebtedness to TTM EBITDA ratio of 2.4x (limit 4.5x) and an Interest Coverage ratio of 4.8x (minimum 2.0x).
- Share Repurchases: Under the $300 million program authorized in April 2022, the company repurchased $56.9 million of shares in the first nine months of 2025. No shares were repurchased in Q3 2025. Approximately $211 million remains available under the program.
- Risks and Contingencies:
- Legal Proceedings: The company faces ongoing asbestos-related litigation and a class action lawsuit regarding grout defects (Rouse et al.). Management does not believe these will have a material adverse effect, though outcomes are uncertain.
- Environmental: The company is involved in environmental investigations and clean-up activities, with a recorded liability of $2.8 million as of August 30, 2025.
- Market Risks: Exposure to foreign currency exchange rates, interest rate fluctuations, and raw material price volatility remains a key risk factor.
Investor Verification Checklist
- Organic Growth Trends: Verify the sustainability of the 1.0% pricing increase and the 1.9% volume decline in Q3, particularly in the Hygiene and Building segments where volume pressures were noted.
- Restructuring Completion: Monitor the remaining $0.3 million to $5.3 million of expected restructuring costs and their impact on future quarters through fiscal 2026.
- Acquisition Integration: Assess the financial contribution and integration progress of recent acquisitions (GEM, Medifill, ND Industries Taiwan) to ensure they deliver projected synergies.
- Working Capital Management: Review the $71.2 million use of cash from changes in working capital YTD, specifically the $42.1 million increase in inventory and $25.8 million decrease in trade payables.
- Debt Refinancing: Confirm the impact of the March 2025 refinancing amendment on future interest expense, noting the reduction in interest rate margins on Term B loans.